Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(1.90)
Shares Outstanding29.2M
Average Volume (10 days)585.6K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$1.42
Sales (TTM)$2.66
Book Value (MRQ)$3.47
Cash Flow (TTM)$1.89
Cash (MRQ)$2.90

Analyst Views

Current Mean RecommendationBuy
Strong Buy2
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Eugene Durenard
Director
12,500
Acquire
Jan 8, 2022
James Nelson
Director
12,500
Acquire
Jan 8, 2022
Richard S. Serbin
Director
12,500
Acquire
Jan 8, 2022
Brian L. Brown
Chief Financial Officer
21,667
Acquire
Nov 23, 2021
Brian L. Brown
Chief Financial Officer
(6,684)
Dispose
Nov 23, 2021

Recent SEC Filings

D
Jan 14, 2022
Insider Buy/Sell
Jan 10, 2022
Insider Buy/Sell
Jan 10, 2022
Insider Buy/Sell
Jan 10, 2022
Insider Buy/Sell
Jan 10, 2022